Make a Living ClubMake a Living Club
  • Home
  • News
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • More
    • Economy
    • Politics
    • Real Estate
Trending Now

John Wiley & Sons, Inc. (WLY) Q2 2026 Earnings Call Transcript

December 4, 2025

General Motors Company (GM) Presents at UBS Global Industrials and Transportation Conference Transcript

December 3, 2025

Verizon: Not A Value Trap, The Math Works (NYSE:VZ)

December 2, 2025

John Hancock Multimanager 2015 Lifetime Portfolio Q3 2025 Commentary

December 1, 2025

BitMine Immersion: Major Test Passed So Far (NYSE:BMNR)

November 30, 2025

United Natural Foods Q1 Preview: Doesn’t Seem Like An Exciting Opportunity Right Now

November 28, 2025
Facebook Twitter Instagram
  • Privacy
  • Terms
  • Press
  • Advertise
  • Contact
Facebook Twitter Instagram
Make a Living ClubMake a Living Club
  • Home
  • News
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • More
    • Economy
    • Politics
    • Real Estate
Sign Up for News & Alerts
Make a Living ClubMake a Living Club
Home » Three GOP appointees, including 2 from Trump, will hear the next phase of major abortion pill case
Politics

Three GOP appointees, including 2 from Trump, will hear the next phase of major abortion pill case

Press RoomBy Press RoomMay 8, 2023
Facebook Twitter Pinterest LinkedIn WhatsApp Email

The New Orleans-based appeals court panel that will oversee the next stage in the blockbuster legal challenge to the availability of medication abortion drugs is made up of three Republican appointees, including one Trump nominee who has called abortion a “moral tragedy.”

Circuit Judges James Ho and Cory Wilson, both Trump nominees, will hear the oral arguments on May 17, alongside Judge Jennifer Walker Elrod, an appointee of George W. Bush.

The lawsuit was brought by anti-abortion doctors and medical organizations who allege the US Food and Drug Administration broke the law when it approved the medication abortion drug mifepristone more than two decades ago.

Last month, US District Judge Matthew Kacsmaryk agreed with their arguments and ruled that the approval of the drug should be suspended. 

However, his ruling was put on hold by the Supreme Court on April 21 and it will remain on hold until the case goes back to the high court, regardless of how the 5th US Circuit Court of Appeals rules on the merits.

Ho, a former Texas solicitor general, is considered one of the most conservative and strident members of the 5th Circuit, having described abortion as a “moral tragedy” in a 2018 concurring opinion.

In a 2019 concurring opinion, Ho also said that a trial judge’s ruling – which struck down a 15-week abortion ban and which was affirmed by the 5th Circuit under the then-standing Roe precedent – displayed “an alarming disrespect for the millions of Americans who believe that babies deserve legal protection during pregnancy as well as after birth, and that abortion is the immoral, tragic, and violent taking of innocent human life.”

The 5th Circuit is considered one of the most conservative in the country has consistently ruled against the Biden Justice Department.

Wilson earlier this year wrote a majority circuit opinion that said that a federal law that bars gun ownership by people under domestic violence was unconstitutional.

Elrod penned an opinion last month that struck down the federal ban on bump stocks, which are attachments that essentially allow shooters to fire semiautomatic rifles continuously with one pull of the trigger.

The medication abortion case is another hugely consequential case to go through the circuit. Mifepristone – the drug being targeted in the lawsuit – is the first pill in the two-pill regimen for terminating a pregnancy. Medication abortion makes up more than half of all abortions obtained in the United States.

In filings last week, the Justice Department told the 5th Circuit that Kacsmaryk’s conclusions that the drug was unsafe rested “on a series of fundamental errors.”

“While FDA justified its scientific conclusions in multiple detailed reviews, including a medical review spanning more than 100 pages and assessing dozens of studies and other scientific information, the district court swept the agency’s judgments aside by substituting its own lay understanding of purportedly contrary studies, offering demonstrably erroneous characterizations of the record,” the DOJ’s filing said. 

The department’s opponents in the case will file a response later on Monday.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Lebanese nationals living in the US will be granted humanitarian relief as Israel-Hezbollah conflict continues

Politics October 17, 2024

Huge fundraising powers Democrats’ hopes to flip the House

Politics October 16, 2024

Small Business Administration disaster loan program is out of money after back-to-back hurricanes

Politics October 15, 2024

Harris advisers zero in on Michigan strategy to overcome anticipated losses among some parts of Democratic coalition

Politics October 14, 2024

How hurricane season is affecting the way Americans follow the Trump-Harris race

Politics October 13, 2024

Walz tries to burnish his everyman image with trip home to Minnesota

Politics October 12, 2024
Add A Comment

Leave A Reply Cancel Reply

Latest News

General Motors Company (GM) Presents at UBS Global Industrials and Transportation Conference Transcript

December 3, 2025

Verizon: Not A Value Trap, The Math Works (NYSE:VZ)

December 2, 2025

John Hancock Multimanager 2015 Lifetime Portfolio Q3 2025 Commentary

December 1, 2025

BitMine Immersion: Major Test Passed So Far (NYSE:BMNR)

November 30, 2025

United Natural Foods Q1 Preview: Doesn’t Seem Like An Exciting Opportunity Right Now

November 28, 2025
Trending Now

The housing crisis is pushing Gen Z into crypto and economic nihilism

November 28, 2025

Voya Infrastructure, Industrials And Materials Fund Q3 2025 Commentary

November 27, 2025

Banco BBVA Argentina S.A. (BBAR) Q3 2025 Earnings Call Transcript

November 26, 2025

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Make a Living is your one-stop news website for the latest personal finance, investing and markets news and updates, follow us now to get the news that matters to you.

We're social. Connect with us:

Facebook Twitter Instagram YouTube LinkedIn
Topics
  • Business
  • Economy
  • Finance
  • Investing
  • Markets
Quick Links
  • Cookie Policy
  • Advertise with us
  • Get in touch
  • Submit News
  • Newsletter

Subscribe to Updates

Get the latest finance, markets, and business news and updates directly to your inbox.

2025 © Make a Living Club. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.